by Primrose Bio | May 21, 2025 | Events
On May 21, 2025, Primrose Bio participated in the Antibody Engineering & Therapeutics Spring Digital Week, a virtual event hosted in collaboration with The Antibody Society. Russell Coleman delivered a featured presentation titled “Pfast™ Protein Expression: A... 
by Primrose Bio | May 17, 2025 | Events
Primrose Bio exhibited at PEGS Boston 2025 from May 12–16, highlighting advancements in complex protein development powered by our proprietary Pfenex Expression Technology® and Pfast™ Feasibility platform. On May 12, Russell... 
by Primrose Bio | May 7, 2025 | Events
Primrose Bio joined global leaders in Berlin for the 3rd Annual mRNA Process Development & Manufacturing Summit, showcasing our innovations in mRNA manufacturing. On Day 1, Advisor Khaled Yamout presented “Smarter RNA Polymerase Selection for Successful mRNA... 
by Primrose Bio | Apr 23, 2025 | Events
Primrose Bio was proud to exhibit and present at the World Vaccine Congress 2025, held April 22–25 in Washington, D.C. Our team shared insights into next-generation solutions for biotherapeutics and vaccine manufacturing, highlighting our Prima RNApols™ platform... 
by Primrose Bio | Mar 20, 2025 | Events
Primrose Bio was proud to participate in Bio-Europe Spring 2025, held March 17–19 in Italy. Representing the team, Alec Tzianabos connected with global partners to discuss our scalable, efficient, and cost-effective manufacturing solutions for complex biologics.... 
by Primrose Bio | Jan 17, 2025 | Events
Primrose Bio kicked off the year at JPM Week 2025 in San Francisco, where our executive team — Helge Zieler (CEO), Simon Latimer (CFO), Michele Rubino (CBO), and Louis J. Cantolupo (VP of Business Development) — met with partners, investors, and biotech...